Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

8(53.3%)

Phase 1

4(26.7%)

Phase 3

1(6.7%)

N/A

1(6.7%)

Phase 4

1(6.7%)

15Total

Phase 2(8)

Phase 1(4)

Phase 3(1)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials

NCT00769522Phase 3Completed

FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia

Role: collaborator

NCT00801216Phase 2Completed

High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement

Role: collaborator

NCT01458730Phase 2Completed

Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Role: collaborator

NCT00951457Phase 1Completed

Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)

Role: collaborator

NCT01325194Phase 2Completed

CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis

Role: collaborator

NCT02863263Not ApplicableTerminated

Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer

Role: lead

NCT03380247Completed

Multimodal Oral Analgesia for Trauma in the Emergency Department

Role: collaborator

NCT01526694Phase 2Completed

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

Role: collaborator

NCT00963534Phase 1Completed

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.

Role: collaborator

NCT01078142Phase 1Completed

Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

Role: collaborator

NCT02664987Completed

Analgesic Treatment for Cancer Pain in South East Asia

Role: lead

NCT01961271Phase 4Completed

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Role: lead

NCT00740415Phase 2Completed

Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma

Role: collaborator

NCT01457144Phase 2Completed

Study of Mantle Cell Lymphoma Treatment by RiBVD

Role: collaborator

NCT02256202Completed

Quality Assurance of Electronic Data Capturing (EDC) in Pain Treatment

Role: collaborator

NCT02126709Phase 2Unknown

The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy

Role: collaborator

NCT00959686Phase 2Completed

Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma

Role: collaborator

NCT01002703Phase 1Unknown

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Role: collaborator

All 18 trials loaded